Acadian Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-20,809
| Closed | -$323K | – | 2274 |
|
|
2021
Q1 | $323K | Sell |
20,809
-40,277
| -66% | -$625K | ﹤0.01% | 1339 |
|
|
2020
Q4 | $969K | Sell |
61,086
-99,464
| -62% | -$1.58M | ﹤0.01% | 999 |
|
|
2020
Q3 | $1.95M | Buy |
160,550
+430
| +0.3% | +$5.23K | 0.01% | 674 |
|
|
2020
Q2 | $1.85M | Buy |
160,120
+33,347
| +26% | +$385K | 0.01% | 763 |
|
|
2020
Q1 | $1.74M | Buy |
126,773
+7,516
| +6% | +$103K | 0.01% | 647 |
|
|
2019
Q4 | $704K | Buy |
119,257
+56,020
| +89% | +$331K | ﹤0.01% | 978 |
|
|
2019
Q3 | $335K | Buy |
63,237
+17,087
| +37% | +$90.5K | ﹤0.01% | 1188 |
|
|
2019
Q2 | $355K | Sell |
46,150
-3,039
| -6% | -$23.4K | ﹤0.01% | 1093 |
|
|
2019
Q1 | $979K | Buy |
49,189
+38,054
| +342% | +$757K | ﹤0.01% | 902 |
|
|
2018
Q4 | $147K | Buy |
+11,135
| New | +$147K | ﹤0.01% | 1183 |
|
|
2016
Q4 | – | Sell |
-16
| Closed | -$1K | – | 1803 |
|
|
2016
Q3 | $1K | Sell |
16
-44,190
| -100% | -$2.76M | ﹤0.01% | 1390 |
|
|
2016
Q2 | $2.5M | Buy |
44,206
+33,428
| +310% | +$1.89M | 0.01% | 483 |
|
|
2016
Q1 | $691K | Buy |
10,778
+10,762
| +67,263% | +$690K | ﹤0.01% | 701 |
|
|
2015
Q4 | $2K | Hold |
16
| – | – | ﹤0.01% | 1351 |
|
|
2015
Q3 | $2K | Hold |
16
| – | – | ﹤0.01% | 1264 |
|
|
2015
Q2 | $2K | Buy |
+16
| New | +$2K | ﹤0.01% | 1325 |
|